|
HY-135794-10mg
|
MedChemexpress LLC
|
11-Ketodihydrotestosterone [CAS 32694-37-4]
|
|
|
|
|
HY-135794-100mg
|
MedChemexpress LLC
|
11-Ketodihydrotestosterone [CAS 32694-37-4]
|
|
|
|
|
HY-135794-5mg
|
MedChemexpress LLC
|
11-Ketodihydrotestosterone [CAS 32694-37-4]
|
|
|
|
|
HY-135794-50mg
|
MedChemexpress LLC
|
11-Ketodihydrotestosterone [CAS 32694-37-4]
|
|
|
|
|
HY-135794-1mL
|
MedChemexpress LLC
|
11-Ketodihydrotestosterone [CAS 32694-37-4] (10mM in DMSO)
|
|
|
|
|
HY-100226-10mg
|
MedChemexpress LLC
|
A-205804 [CAS 251992-66-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-100226-5mg
|
MedChemexpress LLC
|
A-205804 [CAS 251992-66-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-100226-50mg
|
MedChemexpress LLC
|
A-205804 [CAS 251992-66-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-100226-1mL
|
MedChemexpress LLC
|
A-205804 [CAS 251992-66-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-146356-1mg
|
MedChemexpress LLC
|
Adenylyl cyclase type 2 agonist-1 [CAS 2414908-52-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-146356-10mg
|
MedChemexpress LLC
|
Adenylyl cyclase type 2 agonist-1 [CAS 2414908-52-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-146356-5mg
|
MedChemexpress LLC
|
Adenylyl cyclase type 2 agonist-1 [CAS 2414908-52-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1110-1mg
|
MedChemexpress LLC
|
AF12198 [CAS 185413-30-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1110-5mg
|
MedChemexpress LLC
|
AF12198 [CAS 185413-30-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-117407-10mg
|
MedChemexpress LLC
|
ALLO-2 [CAS 1357350-60-7]
|
|
Cancer-programmed cell death
|
|
|
HY-117407-100mg
|
MedChemexpress LLC
|
ALLO-2 [CAS 1357350-60-7]
|
|
Cancer-programmed cell death
|
|
|
HY-117407-5mg
|
MedChemexpress LLC
|
ALLO-2 [CAS 1357350-60-7]
|
|
Cancer-programmed cell death
|
|
|
HY-117407-50mg
|
MedChemexpress LLC
|
ALLO-2 [CAS 1357350-60-7]
|
|
Cancer-programmed cell death
|
|
|
HY-117407-1mL
|
MedChemexpress LLC
|
ALLO-2 [CAS 1357350-60-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-100596-10mg
|
MedChemexpress LLC
|
AS1842856 [CAS 836620-48-5]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100596-100mg
|
MedChemexpress LLC
|
AS1842856 [CAS 836620-48-5]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100596-200mg
|
MedChemexpress LLC
|
AS1842856 [CAS 836620-48-5]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100596-5mg
|
MedChemexpress LLC
|
AS1842856 [CAS 836620-48-5]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100596-50mg
|
MedChemexpress LLC
|
AS1842856 [CAS 836620-48-5]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100596-500mg
|
MedChemexpress LLC
|
AS1842856 [CAS 836620-48-5]
|
|
Metabolism-sugar/lipid metabolism
|
|
